Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Change in Accured Expenses (2016 - 2025)

Regenxbio has reported Change in Accured Expenses over the past 12 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $3.2 million for Q4 2025, up 377.0% from a year ago — trailing twelve months through Dec 2025 was $229000.0 (up 108.78% YoY), and the annual figure for FY2025 was $229000.0, up 108.78%.
  • Change in Accured Expenses for Q4 2025 was $3.2 million at Regenxbio, up from -$420000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for RGNX hit a ceiling of $34.3 million in Q2 2022 and a floor of -$33.6 million in Q4 2022.
  • Median Change in Accured Expenses over the past 5 years was $53500.0 (2021), compared with a mean of $218200.0.
  • Peak annual rise in Change in Accured Expenses hit 51800.0% in 2022, while the deepest fall reached 69565.79% in 2022.
  • Regenxbio's Change in Accured Expenses stood at $29.9 million in 2021, then crashed by 212.2% to -$33.6 million in 2022, then skyrocketed by 115.16% to $5.1 million in 2023, then crashed by 122.82% to -$1.2 million in 2024, then skyrocketed by 377.0% to $3.2 million in 2025.
  • The last three reported values for Change in Accured Expenses were $3.2 million (Q4 2025), -$420000.0 (Q3 2025), and $11.9 million (Q2 2025) per Business Quant data.